Artemisinin inhibits tumour necrosis factor-α-induced vascular smooth muscle cell proliferation in vitro and attenuates balloon injury-induced neointima formation in rats

被引:9
作者
Cao, Qian [1 ]
Jiang, Yan [2 ]
Shi, Jin [1 ]
Liu, Xue [1 ]
Chen, Jie [1 ]
Niu, Tiesheng [1 ]
Li, Xiaodong [1 ]
机构
[1] China Med Univ, Dept Cardiol, Shengjing Hosp, Shenyang 110004, Peoples R China
[2] China Med Univ, Dept Emergency Med, Shengjing Hosp, Shenyang 110004, Peoples R China
关键词
apoptosis; artemisinin; cell cycle; neointima formation; proliferation; TNF-; vascular smooth muscle cells; CYCLIN-E; APOPTOSIS; DIHYDROARTEMISININ; PROGRESSION; EXPRESSION; PATHWAYS; GROWTH;
D O I
10.1111/1440-1681.12375
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to evaluate the effect of artemisinin (ART) on rat vascular smooth muscle cell (VSMC) proliferation induced by tumour necrosis factor (TNF)-, cell cycle arrest, and apoptosis, and its effect on neointima formation after balloon injury of rat carotid artery. Primary rat VSMC were identified by immunofluorescence assay. The proliferation of VSMC induced by TNF- was significantly inhibited by ART treatment in a dose-dependent manner. Treatment with 100-M ART significantly reduced the expression of proliferating cell nuclear antigen. In contrast, the same treatment arrested the cell cycle in G0/G1 phase. Western blot analysis showed that the cell cycle-related proteins cyclin D1, cyclin E, cyclin-dependent kinase 2, and cyclin-dependent kinase 4 were downregulated by ART in TNF--stimulated VSMC. For apoptosis induced by ART, cleaved caspase-3/-9 was detected, and the pro-apoptotic protein Bcl-2-associated X protein was upregulated while the anti-apoptotic protein Bcl-2 was downregulated. The results suggest that ART can effectively inhibit the proliferation of VSMC induced by TNF- through the apoptotic induction pathway and cell cycle arrest. Also, balloon injury indicated that ART significantly inhibited neointima formation in the rat carotid arteries.
引用
收藏
页码:502 / 509
页数:8
相关论文
共 33 条
[1]   The Bcl-2 apoptotic switch in cancer development and therapy [J].
Adams, J. M. ;
Cory, S. .
ONCOGENE, 2007, 26 (09) :1324-1337
[2]   Ways of dying: multiple pathways to apoptosis [J].
Adams, JM .
GENES & DEVELOPMENT, 2003, 17 (20) :2481-2495
[3]   Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities [J].
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) :1360-1369
[4]   Artemisinin inhibits the proliferation, migration, and inflammatory reaction induced by tumor necrosis factor-α in vascular smooth muscle cells through nuclear factor kappa B pathway [J].
Cao, Qian ;
Jiang, Yan ;
Shi, Jin ;
Xu, Changlu ;
Liu, Xiaoxia ;
Yang, Tiangui ;
Fu, Peng ;
Niu, Tiesheng .
JOURNAL OF SURGICAL RESEARCH, 2015, 194 (02) :667-678
[5]   Gene transfer strategies to inhibit neointima formation [J].
Crook, ME ;
Akyürek, LM .
TRENDS IN CARDIOVASCULAR MEDICINE, 2003, 13 (03) :102-106
[6]   Role of smooth muscle cells in the initiation and early progression of atherosclerosis [J].
Doran, Amanda C. ;
Meller, Nahum ;
McNamara, Coleen A. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (05) :812-819
[7]   Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells [J].
Efferth, T .
CURRENT DRUG TARGETS, 2006, 7 (04) :407-421
[8]   Immune and Inflammatory Mechanisms of Atherosclerosis [J].
Galkina, Elena ;
Ley, Klaus .
ANNUAL REVIEW OF IMMUNOLOGY, 2009, 27 :165-197
[9]   Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway [J].
Handrick, Rene ;
Ontikatze, Teona ;
Bauer, Kerstin-Daniela ;
Freier, Florian ;
Ruebel, Amelie ;
Duerig, Jan ;
Belka, Claus ;
Jendrossek, Verena .
MOLECULAR CANCER THERAPEUTICS, 2010, 9 (09) :2497-2510
[10]   Dihydroartemisinin is an inhibitor of ovarian cancer cell growth [J].
Jiao, Yang ;
Ge, Chun-min ;
Meng, Qing-hui ;
Cao, Jian-ping ;
Tong, Jian ;
Fan, Sai-jun .
ACTA PHARMACOLOGICA SINICA, 2007, 28 (07) :1045-1056